Clinical Trial Update: Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a tiotropium inhaler to treat shortness of breath in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Non-small Cell Lung Cancer

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: NSCLC, Dyspnea | Phase 2 | Status: UNKNOWN